4//SEC Filing
O'Leary James J 4
Accession 0001209191-22-007052
CIK 0001805890other
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 7:38 PM ET
Size
7.0 KB
Accession
0001209191-22-007052
Insider Transaction Report
Form 4
O'Leary James J
Chief Medical Officer
Transactions
- Award
Common Stock
2021-08-31+1,722→ 2,022 total - Award
Stock Option (Right to Buy)
2022-02-01+159,000→ 159,000 totalExercise: $7.70Exp: 2032-02-01→ Common Stock (159,000 underlying)
Footnotes (2)
- [F1]These shares were purchased pursuant to the issuer's 2020 Employee Stock Purchase Plan.
- [F2]This option vests in 48 equal monthly installments beginning on March 1, 2022.
Documents
Issuer
Fusion Pharmaceuticals Inc.
CIK 0001805890
Entity typeother
Related Parties
1- filerCIK 0001449753
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 7:38 PM ET
- Size
- 7.0 KB